Gyeonggi-do, South Korea

Hyungsuk Lim

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Hk Inno.n Corporation. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hyungsuk Lim

Introduction

Hyungsuk Lim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations.

Latest Patents

Hyungsuk Lim holds a patent for a preparation containing a benzimidazole derivative. This novel formulation is designed for oral administration and includes a compound of Formula 1 or a pharmaceutically acceptable salt thereof. The formulation also incorporates at least one disintegrant selected from croscarmellose sodium, sodium starch glycolate, and low-substituted hydroxypropylcellulose. This invention exhibits excellent storage stability and effectively prevents a decline in dissolution rate, making it a valuable option for oral administration.

Career Highlights

Hyungsuk Lim is associated with Hk Inno.n Corporation, where he continues to develop innovative pharmaceutical solutions. His work has contributed to advancements in drug formulation and delivery systems.

Collaborations

Hyungsuk Lim collaborates with talented coworkers, including Chun Seon Lyu and Sun Young Park, who contribute to the innovative environment at Hk Inno.n Corporation.

Conclusion

Hyungsuk Lim's contributions to pharmaceutical innovations, particularly through his patented formulation, highlight his role as a significant inventor in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…